Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
73.45
-0.43 (-0.59%)
Oct 29, 2025, 2:22 PM EDT - Market open

PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Incyte stock at 5.11%, Biogen at 5.07%, Vertex Pharmaceuticals at 5.01%, Gilead Sciences at 4.84%, and Royalty Pharma at 4.78%.

Total Holdings
25
Top 10 Percentage
46.55%
Asset Class
Equity
ETF Category
n/a
Assets
229.72M
PE Ratio
17.77

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1INCYIncyte Corporation5.11%127,154
2BIIBBiogen Inc.5.07%78,120
3VRTXVertex Pharmaceuticals Incorporated5.01%27,597
4GILDGilead Sciences, Inc.4.84%93,081
5RPRXRoyalty Pharma plc4.78%296,857
6ILMNIllumina, Inc.4.69%108,181
7AMGNAmgen Inc.4.64%36,883
8REGNRegeneron Pharmaceuticals, Inc.4.59%18,176
9IONSIonis Pharmaceuticals, Inc.4.35%138,155
10EXASExact Sciences Corporation3.46%126,347
11UTHRUnited Therapeutics Corporation3.43%18,842
12PTCTPTC Therapeutics, Inc.3.41%117,792
13MNKDMannKind Corporation3.35%1,431,429
14SRPTSarepta Therapeutics, Inc.3.24%319,055
15VCYTVeracyte, Inc.3.11%200,411
16TECHBio-Techne Corporation2.85%102,586
17NBIXNeurocrine Biosciences, Inc.2.74%42,575
18CPRXCatalyst Pharmaceuticals, Inc.2.70%292,174
19EXELExelixis, Inc.2.62%151,956
20AKBAAkebia Therapeutics, Inc.2.58%1,885,407
21MDGLMadrigal Pharmaceuticals, Inc.2.58%13,712
22DVAXDynavax Technologies Corporation2.53%558,037
23VCELVericel Corporation2.52%159,832
24QGENQiagen N.V.2.49%119,237
25BMRNBioMarin Pharmaceutical Inc.2.31%101,408
Showing 25 of 33 holdings
Subscribe to see the full list
As of Oct 27, 2025